Literature DB >> 673157

The effect of viloxazine hydrochloride on the transport of noradrenaline, dopamine, 5-hydroxytryptamine and gamma-amino-butyric acid in rat brain tissue.

I L Martin, G B Baker, P R Mitchell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 673157     DOI: 10.1016/0028-3908(78)90018-7

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


× No keyword cloud information.
  6 in total

1.  Effects of the optical isomers of 2-amino-3-fluoro-1-phenylpropane (monofluoroamphetamine) hydrochloride on uptake and release of dopamine in rat striatum in vitro.

Authors:  A Benderly; R T Coutts; A L Mak; G B Baker
Journal:  Experientia       Date:  1981-03-15

Review 2.  New Drugs to Treat ADHD: Opportunities and Challenges in Research and Development.

Authors:  David J Heal; Jane Gosden; Sharon L Smith
Journal:  Curr Top Behav Neurosci       Date:  2022

3.  4-Ethoxyamphetamine: effects on intracranial self-stimulation and in vitro uptake and release of 3H-dopamine and 3H-serotonin in the brains of rats.

Authors:  K M Hegadoren; A J Greenshaw; G B Baker; M T Martin-Iverson; B Lodge; S Soin
Journal:  J Psychiatry Neurosci       Date:  1994-01       Impact factor: 6.186

4.  Anticonvulsant and proconvulsant properties of viloxazine hydrochloride: pharmacological and pharmacokinetic studies in rodents and the epileptic baboon.

Authors:  B S Meldrum; G M Anlezark; H K Adam; D T Greenwood
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

5.  New Insights into the Mechanism of Action of Viloxazine: Serotonin and Norepinephrine Modulating Properties.

Authors:  Chungping Yu; Jennie Garcia-Olivares; Shawn Candler; Stefan Schwabe; Vladimir Maletic
Journal:  J Exp Pharmacol       Date:  2020-08-25

Review 6.  Viloxazine in the Management of CNS Disorders: A Historical Overview and Current Status.

Authors:  Robert L Findling; Shawn A Candler; Azmi F Nasser; Stefan Schwabe; Chungping Yu; Jennie Garcia-Olivares; Welton O'Neal; Jeffrey H Newcorn
Journal:  CNS Drugs       Date:  2021-05-18       Impact factor: 5.749

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.